Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 14, 2021; 27(42): 7362-7375
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7362
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7362
Table 2 Symptoms of the studied patients
| Symptom | n (%) |
| Dyspnea | 80 (64.0) |
| Fever | 78 (62.4) |
| Cough | 55 (44.0) |
| Fatigue | 26 (20.8) |
| Disturbed consciousness | 22 (17.6) |
| Sore throat | 15 (12.0) |
| Newly developed hepatic encephalopathy | 15 (12.0) |
| Hepatocellular carcinoma | 15 (12.0) |
| Myalgia | 12 (9.6) |
| Current ascites | 9 (7.2) |
| History of hematemesis from esophageal varices | 9 (7.2) |
| Asymptomatic | 5 (4.0) |
| Diarrhea | 5 (4.0) |
| Arthralgia | 5 (4.0) |
| Anorexia | 4 (3.2) |
| Nausea | 3 (2.4) |
| Vomiting | 3 (2.4) |
| Loss of taste | 2 (1.6) |
| Hemoptysis | 1 (0.8) |
| Abdominal pain | 1 (0.8) |
| Loss of smell | 1 (0.8) |
| Jaundice | 1 (0.8) |
| Rhinorrhea | 1 (0.8) |
- Citation: Afify S, Eysa B, Hamid FA, Abo-Elazm OM, Edris MA, Maher R, Abdelhalim A, Abdel Ghaffar MM, Omran DA, Shousha HI. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World J Gastroenterol 2021; 27(42): 7362-7375
- URL: https://www.wjgnet.com/1007-9327/full/v27/i42/7362.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i42.7362